Bell & Brown Wealth Advisors LLC Acquires Shares of 14,533 Corteva, Inc. $CTVA

Key Points

• Bell & Brown Wealth Advisors initiated a position in Corteva, buying 14,533 shares valued at approximately $1.23 million. Institutional investors collectively own 81.54% of the company.
• Corteva reported quarterly earnings of $2.30 per share, beating estimates of $2.24, while revenue of $6.38 billion fell short of expectations and declined 1.2% year over year. The company reaffirmed fiscal 2026 EPS guidance of $3.60–$3.80.
• The company declared a quarterly dividend of $0.18 per share, equivalent to a 0.9% annual yield. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $91.50, compared with a recent share price of $78.51.

Bell & Brown Wealth Advisors LLC bought a new position in Corteva, Inc. (NYSE:CTVA - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 14,533 shares of the company's stock, valued at approximately $1,231,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. BlackRock Inc. purchased a new stake in shares of Corteva during the 2nd quarter valued at about $4,560,180,000. Harris Associates L P lifted its holdings in Corteva by 168.1% in the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company's stock valued at $1,141,268,000 after acquiring an additional 10,675,052 shares during the period. Norges Bank bought a new position in shares of Corteva in the 4th quarter worth approximately $504,001,000. Royal Bank of Canada grew its position in Corteva by 202.1% during the first quarter. Royal Bank of Canada now owns 7,458,624 shares of the company's stock valued at $624,362,000 after buying an additional 4,989,371 shares during the period. Finally, Bank of New York Mellon Corp purchased a new stake in Corteva during the second quarter valued at approximately $392,447,000. 81.54% of the stock is currently owned by institutional investors.

Corteva Price Performance

NYSE CTVA opened at $78.51 on Thursday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $90.97. The company has a market cap of $52.38 billion, a price-to-earnings ratio of 51.99, a PEG ratio of 2.39 and a beta of 0.57. The stock's fifty day moving average price is $81.92 and its 200 day moving average price is $80.15.

Corteva (NYSE:CTVA - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.06. The company had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. Corteva's quarterly revenue was down 1.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, equities research analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be given a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva's dividend payout ratio is currently 47.68%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on CTVA. UBS Group reduced their price target on Corteva from $89.00 to $85.00 and set a "neutral" rating for the company in a research report on Tuesday. Morgan Stanley upped their price objective on Corteva from $84.00 to $95.00 and gave the company an "overweight" rating in a research report on Thursday, May 28th. Oppenheimer increased their target price on shares of Corteva from $89.00 to $95.00 and gave the company an "outperform" rating in a research note on Thursday, July 23rd. JPMorgan Chase & Co. upped their price target on shares of Corteva from $77.00 to $83.00 and gave the stock a "neutral" rating in a report on Monday, August 3rd. Finally, Weiss Ratings lowered Corteva from a "hold (c+)" rating to a "hold (c)" rating in a research note on Monday, August 3rd. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, Corteva currently has an average rating of "Moderate Buy" and an average price target of $91.50.

Corteva Company Profile

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source